Michael Aaron Brodney,Jennifer Elizabeth Davoren,Amy Beth Dounay,Ivan Viktorovich Efremov,David Lawrence Firman Gray,Michael Eric Green,Jaclyn Louise Henderson,Chewah Lee,Scot Richard Mente,Steven Vic
申请号：
US16539865
公开号：
US20190367485A1
申请日:
2019.08.13
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention provides, in part, compounds of Formula I:and pharmaceutically acceptable salts thereof； processes for the preparation of； intermediates used in the preparation of； and compositions containing such compounds or salts, and their uses for treating D1-mediated (or D1-associated) disorders including, e.g., schizophrenia (e.g., its cognitive and negative symptoms), cognitive impairment (e.g., cognitive impairment associated with schizophrenia, AD, PD, or pharmacotherapy therapy), and Parkinson's disease.
